Rajan L Shah, MD
Cardiac Electrophysiology · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 13
Offices
13 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Eden Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shah’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A129737 · Current
Licensed to practise in California · since 2014 · expires 2027-11-30 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$261,097
Medicare paid this office $261,097 for 913 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $22,972 | $104 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 25 | $19,261 | $770 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 105 | $16,336 | $59 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 38 | $16,089 | $423 |
| Return visit (30+ min) | 116 | $14,161 | $112 |
See all 36 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $22,972 | $104 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 25 | $19,261 | $770 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 105 | $16,336 | $59 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 38 | $16,089 | $423 |
| Return visit (30+ min) | 116 | $14,161 | $112 |
| Long return visit (40+ min) | 80 | $14,000 | $163 |
| Critical care, first 30-74 minutes | 49 | $13,010 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $12,240 | $153 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $11,467 | $88 |
| Insertion of implantable defibrillator system | 11 | $8,968 | $747 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 139 | $8,057 | $21 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 20 | $8,044 | $251 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 15 | $6,060 | $379 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 95 | $6,056 | $23 |
| Insertion of permanent leadless pacemaker using imaging guidance | 15 | $5,931 | $395 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 18 | $5,295 | $252 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 307 | $4,738 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 193 | $4,315 | $22 |
| New patient visit (60+ min) | 25 | $4,229 | $169 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 44 | $3,694 | $30 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,537 | $295 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 48 | $2,879 | $56 |
| Heart rhythm recording of continous external ekg over 8-15 days | 184 | $2,372 | $13 |
| New patient visit (45+ min) | 16 | $2,345 | $147 |
| Programming of dual lead pacemaker system | 48 | $2,197 | $30 |
| Programming of heart rhythm stimulation after drug infusion | 21 | $1,318 | $60 |
| Short return visit (20+ min) | 11 | $873 | $79 |
| Insertion of heart rhythm monitor under skin | 14 | $839 | $60 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $749 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 39 | $711 | $18 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $609 | $20 |
| Programming of single lead pacemaker system | 12 | $413 | $26 |
| Programming of multiple lead pacemaker system | 11 | $403 | $37 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 30 | $391 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $270 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $248 | $23 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 100 | More than 98% of doctors who do this |
Who their Medicare patients are
913 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 21% · Women 47% · Also on Medicaid 28% · Health risk score 1.72. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 50% · Coronary heart disease 42% · Heart failure 42% · Chronic kidney disease 39% · Diabetes 33% · Depression 21% · Cancer 18% · Stroke 18% · COPD 17% · Dementia 10%.
The office billed $1,301,990, Medicare allowed $338,200 and paid $261,097; for 3,213 services of 80 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 913 | 3,213 | 77 | 1.72 | $1,301,990 | $261,097 |
| 2023 | 1,157 | 4,010 | 77 | 1.68 | $1,454,995 | $237,346 |
| 2022 | 1,403 | 4,487 | 76 | 1.53 | $1,515,616 | $261,447 |
| 2021 | 1,259 | 3,992 | 76 | 1.63 | $1,846,648 | $300,974 |
| 2020 | 362 | 594 | 76 | 1.58 | $414,389 | $54,710 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 31 services
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 123 | $19,655 | $21 |
| Long return visit (40+ min) | 111 | $18,404 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $14,690 | $104 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 15 | $11,865 | $791 |
| Critical care, first 30-74 minutes | 43 | $10,284 | $180 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 166 | $10,180 | $22 |
| Return visit (30+ min) | 75 | $8,448 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $7,994 | $154 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 117 | $7,744 | $24 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,744 | $430 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 331 | $6,994 | $21 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 19 | $6,460 | $258 |
| New patient visit (60+ min) | 33 | $6,033 | $183 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 52 | $4,275 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $3,908 | $60 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 12 | $3,876 | $258 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 28 | $3,661 | $21 |
| Programming of dual lead pacemaker system | 42 | $3,019 | $60 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 117 | $2,260 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 137 | $2,216 | $13 |
| New patient visit (45+ min) | 14 | $1,626 | $116 |
| Programming of heart rhythm stimulation after drug infusion | 21 | $1,613 | $77 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,235 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 149 | $1,059 | $7 |
| Programming of dual lead implantable defibrillator system | 13 | $1,026 | $73 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 14 | $1,001 | $67 |
| Heart rhythm recording of continous external ekg over 8-15 days | 86 | $945 | $11 |
| Telehealth originating site facility fee | 24 | $519 | $20 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 34 | $342 | $10 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 27 | $312 | $12 |
| Electrocardiogram (ecg) 2-day continuous | 17 | $213 | $13 |
2022: 31 services
| Long return visit (40+ min) | 137 | $23,616 | $142 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 123 | $22,490 | $22 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 19 | $17,996 | $947 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $14,556 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $13,016 | $87 |
| New patient visit (60+ min) | 66 | $12,397 | $188 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $12,014 | $445 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 435 | $10,058 | $23 |
| Critical care, first 30-74 minutes | 39 | $10,014 | $189 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 145 | $9,574 | $23 |
| Insertion of implantable defibrillator system | 11 | $8,792 | $799 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 21 | $8,694 | $263 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 101 | $7,238 | $24 |
| Insertion of permanent leadless pacemaker using imaging guidance | 16 | $6,272 | $392 |
| Return visit (30+ min) | 48 | $5,349 | $111 |
| Programming of dual lead pacemaker system | 54 | $4,579 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,368 | $61 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 45 | $4,063 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 205 | $3,389 | $13 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 25 | $2,486 | $21 |
| Programming of heart rhythm stimulation after drug infusion | 24 | $2,349 | $98 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 112 | $2,250 | $20 |
| Heart rhythm recording of continous external ekg over 8-15 days | 142 | $1,924 | $14 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,700 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 196 | $1,285 | $6 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 13 | $1,113 | $86 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 70 | $786 | $11 |
| Electrocardiogram (ecg) 2-day continuous | 57 | $734 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 32 | $600 | $19 |
| Programming of dual lead pacemaker system | 11 | $406 | $34 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 31 | $357 | $11 |
2021: 34 services
| Long return visit (40+ min) | 175 | $36,467 | $145 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 104 | $18,357 | $23 |
| New patient visit (60+ min) | 95 | $16,931 | $178 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 17 | $16,508 | $971 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $16,239 | $439 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $14,839 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $12,805 | $175 |
| Insertion of implantable defibrillator system | 15 | $12,227 | $815 |
| Critical care, first 30-74 minutes | 37 | $11,979 | $200 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 22 | $11,412 | $368 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 443 | $10,050 | $22 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 24 | $9,730 | $405 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 120 | $8,030 | $26 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 27 | $7,179 | $256 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 87 | $5,453 | $26 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,377 | $448 |
| Programming of dual lead pacemaker system | 50 | $4,596 | $68 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 12 | $4,413 | $368 |
| Programming of heart rhythm stimulation after drug infusion | 31 | $3,922 | $127 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 35 | $3,266 | $33 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 29 | $3,221 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 48 | $3,000 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 144 | $2,576 | $14 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 111 | $2,206 | $20 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $1,995 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 131 | $1,892 | $14 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,532 | $102 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,256 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 130 | $1,035 | $7 |
| Return visit (30+ min) | 12 | $915 | $76 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 72 | $818 | $11 |
| Electrocardiogram (ecg) 2-day continuous | 47 | $745 | $16 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 35 | $491 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 18 | $342 | $19 |
2020: 9 services
| New patient visit (60+ min) | 34 | $6,357 | $187 |
| Long return visit (40+ min) | 35 | $5,775 | $126 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 188 | $4,559 | $24 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,856 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,698 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 41 | $1,477 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 23 | $635 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $416 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $108 | $8 |
Medicaid work
$328 in 2024
Medicaid paid $328 for 53 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 15 | $230 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 38 | $99 |
| 2024 | 53 | 2 | 15 | $328 |
| 2023 | 843 | 10 | 42 | $5,965 |
| 2022 | 807 | 8 | 29 | $5,123 |
| 2021 | 496 | 6 | 25 | $1,928 |
| 2020 | 12 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 179 | $2,318 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 385 | $1,452 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 134 | $873 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 18 | $436 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 38 | $330 |
| XTRNL ECG REC<48 HRS REC | 13 | $267 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 26 | $132 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $69 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 25 | $67 |
| XTRNL ECG REC<48 HR R&I | 13 | $21 |
2022
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 120 | $1,123 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 31 | $1,107 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 270 | $967 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 141 | $636 |
| XTRNL ECG REC<48 HRS REC | 45 | $513 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 101 | $382 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 53 | $366 |
| XTRNL ECG REC<48 HR R&I | 46 | $29 |
2021
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, including analysis of 1 or more recorded physiologic cardiovascular data elements from all internal and external sensors, analysis, review(s) and report(s) by a physician or other qualified health care professional | 257 | $642 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 108 | $541 |
| XTRNL ECG REC<48 HRS REC | 31 | $293 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 55 | $284 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $118 |
| XTRNL ECG REC<48 HR R&I | 32 | $50 |
2020
| External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation | 12 | $0 |
Drugs they prescribed that Part D paid
$321,284
Pharmacies billed $321,284 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 889) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
604 generic and 285 brand-name prescriptions · $321,284 in drug cost · 17 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 163 | $180,379 | $1,107 |
| Xarelto | 49 | $56,485 | $1,153 |
| Multaq | 24 | $36,530 | $1,522 |
| Entresto | 15 | $15,090 | $1,006 |
| Mexiletine | 11 | $1,421 | $129 |
See all 20 drugs
| Eliquis | 163 | $180,379 | $1,107 |
| Xarelto | 49 | $56,485 | $1,153 |
| Multaq | 24 | $36,530 | $1,522 |
| Entresto | 15 | $15,090 | $1,006 |
| Mexiletine | 11 | $1,421 | $129 |
| Metoprolol | 96 | $1,381 | $14 |
| Amiodarone | 63 | $1,285 | $20 |
| Flecainide Acetate | 24 | $734 | $31 |
| Rosuvastatin | 13 | $589 | $45 |
| Spironolactone | 41 | $416 | $10 |
| Losartan | 43 | $321 | $7 |
| Carvedilol | 31 | $316 | $10 |
| Sotalol | 15 | $278 | $19 |
| Metoprolol | 26 | $272 | $10 |
| Sucralfate | 14 | $268 | $19 |
| Lisinopril | 28 | $262 | $9 |
| Furosemide | 31 | $247 | $8 |
| Atorvastatin | 20 | $167 | $8 |
| Pantoprazole | 20 | $128 | $6 |
| Doxycycline Hyclate | 13 | $68 | $5 |
Year by year
| 2024 | 889 | 218 | 0% (0) | 32% | $321,284 |
| 2023 | 1,142 | 244 | 0% (0) | 34% | $506,755 |
| 2022 | 1,059 | 235 | None | 32% | $405,560 |
| 2021 | 660 | 169 | 0% (0) | 20% | $114,556 |
| 2020 | 39 | 25 | None | None | $1,291 |
| 2019 | 12 | None | 0% (0) | None | $1,075 |
| 2018 | 194 | 40 | 0% (0) | 13% | $6,917 |
| 2017 | 309 | 50 | 0% (0) | 13% | $9,155 |
| 2016 | 277 | 37 | 0% (0) | 14% | $8,858 |
| 2015 | 170 | 22 | 0% (0) | None | $7,658 |
| 2014 | 55 | None | 0% (0) | None | $11,752 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Eliquis | 243 | $298,683 | $1,229 |
| Multaq | 55 | $86,217 | $1,568 |
| Xarelto | 53 | $66,788 | $1,260 |
| Entresto | 12 | $19,709 | $1,642 |
| Dofetilide | 16 | $8,161 | $510 |
| Metoprolol | 96 | $2,561 | $27 |
| Amiodarone | 43 | $1,200 | $28 |
| Atorvastatin | 64 | $992 | $15 |
| Diltiazem 24hr Er (Cd) | 19 | $937 | $49 |
| Losartan | 55 | $876 | $16 |
| Bumetanide | 13 | $753 | $58 |
| Sucralfate | 40 | $735 | $18 |
| Flecainide Acetate | 17 | $733 | $43 |
| Carvedilol | 46 | $721 | $16 |
| Isosorbide Mononitrate Er | 11 | $648 | $59 |
| Digoxin | 14 | $441 | $32 |
| Sotalol | 12 | $412 | $34 |
| Spironolactone | 29 | $391 | $13 |
| Metoprolol | 42 | $356 | $8 |
| Lisinopril | 28 | $293 | $10 |
| Furosemide | 33 | $269 | $8 |
| Pantoprazole | 32 | $233 | $7 |
| Doxycycline Hyclate | 16 | $100 | $6 |
2022: 25 drugs
| Eliquis | 186 | $209,689 | $1,127 |
| Xarelto | 65 | $73,320 | $1,128 |
| Multaq | 41 | $62,725 | $1,530 |
| Entresto | 15 | $23,613 | $1,574 |
| Dofetilide | 22 | $15,443 | $702 |
| Metoprolol | 94 | $2,086 | $22 |
| Bumetanide | 17 | $1,466 | $86 |
| Flecainide Acetate | 20 | $1,383 | $69 |
| Carvedilol | 57 | $1,053 | $18 |
| Atorvastatin | 66 | $952 | $14 |
| Diltiazem 24hr Er (Cd) | 19 | $911 | $48 |
| Ezetimibe | 11 | $739 | $67 |
| Sucralfate | 25 | $596 | $24 |
| Hydralazine | 17 | $586 | $34 |
| Amiodarone | 13 | $425 | $33 |
| Losartan | 38 | $382 | $10 |
| Spironolactone | 27 | $363 | $13 |
| Digoxin | 14 | $343 | $24 |
| Doxycycline Hyclate | 18 | $291 | $16 |
| Rosuvastatin | 16 | $273 | $17 |
| Metoprolol | 46 | $239 | $5 |
| Lisinopril | 35 | $224 | $6 |
| Furosemide | 36 | $190 | $5 |
| Pantoprazole | 21 | $132 | $6 |
| Amlodipine Besylate | 13 | $110 | $8 |
2021: 18 drugs
| Eliquis | 51 | $57,798 | $1,133 |
| Xarelto | 18 | $18,526 | $1,029 |
| Entresto | 15 | $13,377 | $892 |
| Metoprolol | 72 | $1,640 | $23 |
| Flecainide Acetate | 11 | $935 | $85 |
| Atorvastatin | 50 | $852 | $17 |
| Verapamil Sr | 11 | $776 | $71 |
| Carvedilol | 41 | $691 | $17 |
| Amiodarone | 18 | $663 | $37 |
| Diltiazem 24hr Er (Cd) | 16 | $635 | $40 |
| Spironolactone | 27 | $412 | $15 |
| Hydralazine | 16 | $328 | $20 |
| Metoprolol | 68 | $323 | $5 |
| Losartan | 13 | $232 | $18 |
| Lisinopril | 26 | $212 | $8 |
| Furosemide | 34 | $208 | $6 |
| Amlodipine Besylate | 18 | $188 | $10 |
| Doxycycline Hyclate | 13 | $177 | $14 |
2018: 6 drugs
| Eliquis | 11 | $3,817 | $347 |
| Atorvastatin | 51 | $824 | $16 |
| Nifedipine Er | 12 | $329 | $27 |
| Lisinopril | 16 | $195 | $12 |
| Clopidogrel | 17 | $131 | $8 |
| Carvedilol | 15 | $88 | $6 |
2017: 10 drugs
| Atorvastatin | 60 | $1,040 | $17 |
| Metoprolol | 22 | $858 | $39 |
| Isosorbide Mononitrate Er | 13 | $339 | $26 |
| Lisinopril | 38 | $256 | $7 |
| Clopidogrel | 26 | $239 | $9 |
| Carvedilol | 22 | $213 | $10 |
| Spironolactone | 23 | $146 | $6 |
| Furosemide | 24 | $122 | $5 |
| Amlodipine Besylate | 18 | $60 | $3 |
| Metoprolol | 14 | $48 | $3 |
2016: 8 drugs
| Atorvastatin | 49 | $901 | $18 |
| Metoprolol | 15 | $458 | $31 |
| Isosorbide Mononitrate Er | 21 | $453 | $22 |
| Carvedilol | 20 | $326 | $16 |
| Lisinopril | 39 | $227 | $6 |
| Metoprolol | 28 | $191 | $7 |
| Furosemide | 20 | $78 | $4 |
| Spironolactone | 12 | $55 | $5 |
2015: 3 drugs
| Atorvastatin | 23 | $272 | $12 |
| Benazepril | 12 | $44 | $4 |
| Amlodipine Besylate | 11 | $43 | $4 |
Money from drug and device companies
$20,875 in 2025
| 2025 | 7 | 80 | $17,188 | $20,875 |
| 2024 | 6 | 74 | $3,594 | $8,201 |
| 2023 | 4 | 31 | None | $1,559 |
| 2022 | 3 | 17 | None | $903 |
| 2021 | 6 | 11 | $2,200 | $2,745 |
| 2020 | 3 | 19 | None | $1,940 |
| 2019 | 3 | 24 | None | $1,646 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Therapies | $19,292 | 42 payments
|
| Abbott Laboratories | Aveir | $581 | 24 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $473 | 5 payments
|
| Medtronic | Omniasecure Mri Surescan | $209 | 2 payments
|
| Biosense Webster | Carto 3 | $173 | 5 payments
|
| Biotronik | Solia | $111 | 1 payment
|
See all 80 published payments
| Biosense Webster | Meals · 2025-12-15 | Carto 3 | $26 |
| Biosense Webster | Meals · 2025-12-10 | Carto 3 | $35 |
| Boston Scientific | Consulting · 2025-12-04 | General - Therapies | $2,813 |
| Biosense Webster | Meals · 2025-12-03 | Carto 3 | $37 |
| Medtronic | Meals · 2025-12-01 | Omniasecure Mri Surescan | $159 |
| Boston Scientific | Meals · 2025-11-13 | Accolade Sr | $9 |
| Ebr Systems | Meals · 2025-11-11 | None | $36 |
| Boston Scientific | Meals · 2025-10-29 | Emblem Mri S-Icd | $13 |
| Abbott Laboratories | Meals · 2025-10-28 | Ensite Precision | $86 |
| Boston Scientific | Meals · 2025-10-24 | General - Therapies | $117 |
| Boston Scientific | Meals · 2025-10-22 | Accolade Sr | $15 |
| Abbott Laboratories | Meals · 2025-10-22 | Ensite Precision | $17 |
| Boston Scientific | Meals · 2025-10-21 | Accolade Sr | $14 |
| Boston Scientific | Meals · 2025-10-20 | Emblem Mri S-Icd | $11 |
| Boston Scientific | Meals · 2025-10-16 | Acuity Steerable | $7 |
| Boston Scientific | Meals · 2025-10-14 | Emblem Mri S-Icd | $5 |
| Boston Scientific | Meals · 2025-10-08 | Emblem Mri S-Icd | $13 |
| Abbott Laboratories | Meals · 2025-09-26 | Aveir | $24 |
| Abbott Laboratories | Meals · 2025-09-26 | Aveir | $8 |
| Abbott Laboratories | Meals · 2025-09-26 | Aveir | $5 |
| Abbott Laboratories | Meals · 2025-09-26 | Aveir | $24 |
| Boston Scientific | Meals · 2025-09-25 | Lux-Dx Insertable Cardiac Monitor | $82 |
| Boston Scientific | Meals · 2025-09-24 | S-Icd System Magnet | $7 |
| Boston Scientific | Meals · 2025-09-24 | Lux-Dx Insertable Cardiac Monitor | $74 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $103 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $53 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $89 |
| AtriCure | Meals · 2025-09-12 | Epi-Sense Guided Coagulation System With Visitrax | $175 |
| Boston Scientific | Meals · 2025-09-11 | Ingevity+ | $33 |
| Boston Scientific | Meals · 2025-09-06 | General - Tachy | $16 |
| Boston Scientific | Meals · 2025-09-05 | Accolade Sr | $5 |
| Boston Scientific | Meals · 2025-09-05 | Emblem Mri S-Icd | $7 |
| Boston Scientific | Meals · 2025-08-30 | Emblem Mri S-Icd | $21 |
| Boston Scientific | Meals · 2025-08-29 | Sq-Rx Pulse Generator | $6 |
| Biosense Webster | Meals · 2025-08-20 | Carto 3 | $17 |
| Abbott Laboratories | Meals · 2025-08-18 | Aveir | $11 |
| Boston Scientific | Paid to speak or teach · 2025-08-07 | Ingevity Mri | $7,500 |
| Boston Scientific | Paid to speak or teach · 2025-08-07 | Ingevity Mri | $625 |
| Boston Scientific | Meals · 2025-07-31 | Ingevity+ | $8 |
| Boston Scientific | Meals · 2025-07-31 | Accolade Sr | $4 |
| Boston Scientific | Meals · 2025-07-31 | Lux-Dx Insertable Cardiac Monitor | $38 |
| Boston Scientific | Meals · 2025-07-18 | Ingevity+ | $95 |
| Boston Scientific | Travel · 2025-07-18 | Ingevity+ | $72 |
| Boston Scientific | Travel · 2025-07-18 | Ingevity+ | $34 |
| Boston Scientific | Meals · 2025-07-17 | Ingevity+ | $56 |
| Boston Scientific | Travel · 2025-07-17 | Ingevity+ | $251 |
| Boston Scientific | Travel · 2025-07-17 | Ingevity+ | $34 |
| Boston Scientific | Travel · 2025-07-16 | Ingevity+ | $633 |
| Boston Scientific | Consulting · 2025-07-10 | General - Therapies | $1,875 |
| Abbott Laboratories | Meals · 2025-06-11 | Aveir | $7 |
| Abbott Laboratories | Meals · 2025-06-11 | Aveir | $7 |
| Abbott Laboratories | Meals · 2025-06-02 | Aveir | $17 |
| Boston Scientific | Paid to speak or teach · 2025-05-29 | General - Therapies | $1,875 |
| Abbott Laboratories | Meals · 2025-05-27 | Ensite Precision | $25 |
| Abbott Laboratories | Meals · 2025-05-27 | Ensite Precision | $63 |
| Boston Scientific | Meals · 2025-05-14 | General - Therapies | $99 |
| Medtronic | Meals · 2025-05-14 | Aurora Ev-Icd Mri Surescan | $50 |
| Boston Scientific | Consulting · 2025-05-01 | General - Therapies | $2,500 |
| Boston Scientific | Meals · 2025-04-24 | General - Therapies | $75 |
| Boston Scientific | Meals · 2025-04-05 | Lux-Dx Insertable Cardiac Monitor | $20 |
| Abbott Laboratories | Meals · 2025-03-24 | Aveir | $21 |
| Abbott Laboratories | Meals · 2025-03-24 | Aveir | $22 |
| Abbott Laboratories | Meals · 2025-03-21 | Aveir | $6 |
| Abbott Laboratories | Meals · 2025-03-21 | Aveir | $4 |
| Abbott Laboratories | Meals · 2025-03-21 | Aveir | $15 |
| Abbott Laboratories | Meals · 2025-03-21 | Aveir | $24 |
| Abbott Laboratories | Meals · 2025-03-21 | Aveir | $35 |
| Biotronik | Meals · 2025-02-27 | Solia | $111 |
| Boston Scientific | Meals · 2025-02-13 | General - Brady | $13 |
| Boston Scientific | Meals · 2025-02-13 | General - Brady | $6 |
| Biosense Webster | Meals · 2025-02-06 | Carto 3 | $58 |
| Boston Scientific | Meals · 2025-02-06 | Accolade Sr | $56 |
| Boston Scientific | Meals · 2025-02-06 | General - Brady | $35 |
| Boston Scientific | Meals · 2025-01-22 | General - Brady | $122 |
| Abbott Laboratories | Meals · 2025-01-14 | Ensite Precision | $85 |
| AtriCure | Meals · 2025-01-10 | Epi-Sense Guided Coagulation System With Visitrax | $53 |
| Abbott Laboratories | Meals · 2025-01-07 | Aveir | $25 |
| Abbott Laboratories | Meals · 2025-01-07 | Aveir | $18 |
| Abbott Laboratories | Meals · 2025-01-07 | Aveir | $13 |
| Abbott Laboratories | Meals · 2025-01-07 | Aveir | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $8,201
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $4,117 | 29 payments
|
| Medtronic | Selectsecure | $2,055 | 14 payments
|
| Abbott Laboratories | Aveir | $1,759 | 25 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $143 | 2 payments
|
| Biosense Webster | Carto 3 | $104 | 3 payments
|
| iRhythm Technologies | Zio Monitor | $24 | 1 payment
|
2023: $1,559
| Boston Scientific | Rhythmia Mapping System | $763 | 13 payments
|
| Abbott Laboratories | Ensite Precision | $443 | 9 payments
|
| Biosense Webster | Carto 3 | $320 | 8 payments
|
| Medtronic | Micra | $32 | 1 payment
|
2022: $903
| Abbott Laboratories | Ensite Precision | $594 | 10 payments
|
| Biosense Webster | Carto 3 | $283 | 6 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $26 | 1 payment
|
2021: $2,745
| Abbott Laboratories | Accent Pacemaker | $2,600 | 5 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $43 | 1 payment
|
| Medtronic | Micra | $40 | 2 payments
|
| Boston Scientific | Emblem | $30 | 1 payment
|
| Biosense Webster | Carto 3 | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $11 | 1 payment
|
2020: $1,940
| Medtronic Vascular | None | $1,689 | 12 payments
|
| Boston Scientific | General - Therapies | $140 | 1 payment
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $110 | 6 payments
|
2019: $1,646
| Abbott Laboratories | Ensite Cardiac Mapping System | $637 | 12 payments
|
| Medtronic Vascular | Visia Af | $610 | 9 payments
|
| Boston Scientific | General Structural Heart | $399 | 3 payments
|
Professional record
- NPI
- 1679833867
- Licence
- CA A129737California A129737: Current · expires 2027-11-30
- Trained
- Wayne State University School of Medicine, 2012
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 365 Hawthorne Ave Ste 201, Oakland, CA, 94609
- NPI first listed
- 2012-05-21
- NPI last updated
- 2024-10-17
- NPI record certified
- 2024-10-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 365 Hawthorne Ave Ste 201, Oakland, CA, 94609